AlphaYou
Overview
Smart money at a glance
Filings to Oct 13, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
Market overview
Fundamentals Jun 16- 52-wk high
- $7.15
- 52-wk low
- $0.35
- Mkt cap
- $3.3M
- P/E
- 0.0x
- Fwd P/E
- 158.7x
- Beta
- 0.47
- P/S
- 1.6x
- P/B
- 0.3x
- Profit margin
- +0.0%
- Op margin
- -636.0%
- ROE
- -306.8%
What do analysts expect?
No analyst estimates.
Questions about BNBX filings
Are insiders buying or selling Applied DNA Sciences, Inc. (BNBX) stock?
Neither. Applied DNA Sciences, Inc. (BNBX) insiders filed no open-market purchases or sales in the 90 days to Oct 13, 2026, according to SEC Form 4 filings.
Which members of Congress have traded BNBX recently?
None. No member of Congress disclosed a BNBX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this BNBX smart-money data?
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
3 funds hold a position.
How top traders are positioned
No tracked top-trader positions in BNBX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No reported figure for the latest quarter.
Company release linked above, where available
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Mar 31, 2026 | May 15, 2026 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 14, 2025 | $20.79 / -$37.50Alpha Vantage | +$58.29 beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 15, 2025 | -$230.31 / -$45.00Alpha Vantage | -$185.31 miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 13, 2025 | -$27.84 / -$0.31Alpha Vantage | -$27.53 miss | Unavailable | Unavailable |
| Sep 30, 2024 | Dec 18, 2024 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2024 | Aug 8, 2024 | $0.47 / -$3.70Alpha Vantage | +112.70% beat | Unavailable | Unavailable |
| Mar 31, 2024 | May 10, 2024 | -$3981.73 / -$4.50Alpha Vantage | -$3977.23 miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
Is the business strong?
Fairly priced and running thin margins.
- Net margin
- 0.0%
- P/E
- 0.00
- Forward P/E
- 158.73
- Market cap
- $3M
Valuation
- P/S1.57
- P/B0.26
Quality
- Operating margin-636.0%
- ROE-306.8%
- ROA-152.1%
Growth
- Beta0.47
Technicals
Price structure
Market data unavailable.